Buy Vital Therapies Stock | VTL Stock Price & Latest News | Public.com
VTL

Vital Therapies

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Vital Therapies (VTL) stock trends here

    About VTL

    Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-83...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$339,36M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$28.21
    1 Year Low$4.19
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app